PharmChem Inc
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
PharmChem Inc (PCHM) - Total Assets
Latest total assets as of December 2024: $2.73 Million USD
Based on the latest financial reports, PharmChem Inc (PCHM) holds total assets worth $2.73 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PharmChem Inc - Total Assets Trend (1989–2024)
This chart illustrates how PharmChem Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PharmChem Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
PharmChem Inc's total assets of $2.73 Million consist of 97.1% current assets and 2.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 59.6% |
| Accounts Receivable | $726.51K | 26.6% |
| Inventory | $227.93K | 8.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.55K | 0.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1989–2024)
This chart illustrates how PharmChem Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PharmChem Inc's current assets represent 97.1% of total assets in 2024, an increase from 45.8% in 1989.
- Cash Position: Cash and equivalents constituted 59.6% of total assets in 2024, up from 9.4% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 23.0% in 1989.
- Asset Diversification: The largest asset category is accounts receivable at 26.6% of total assets.
PharmChem Inc Competitors by Total Assets
Key competitors of PharmChem Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
PharmChem Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - PharmChem Inc generates 2.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, PharmChem Inc generates $ 50.50 in net profit.
PharmChem Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.70 | 5.20 | 0.79 |
| Quick Ratio | 4.30 | 4.42 | 0.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.09 Million | $ 2.13 Million | $ -2.21 Million |
PharmChem Inc - Advanced Valuation Insights
This section examines the relationship between PharmChem Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.00 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $2.73 Million |
| Market Capitalization | $32.35K USD |
Valuation Analysis
Below Book Valuation: The market values PharmChem Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: PharmChem Inc's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for PharmChem Inc (1989–2024)
The table below shows the annual total assets of PharmChem Inc from 1989 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.73 Million | -1.14% |
| 2023-12-31 | $2.77 Million | -32.25% |
| 2022-12-31 | $4.08 Million | +20.38% |
| 2021-12-31 | $3.39 Million | -60.80% |
| 2020-12-31 | $8.65 Million | +25.03% |
| 2019-12-31 | $6.92 Million | +18.03% |
| 2018-12-31 | $5.86 Million | +28.34% |
| 2017-12-31 | $4.57 Million | +26.43% |
| 2016-12-31 | $3.61 Million | -78.32% |
| 2003-12-31 | $16.66 Million | -26.49% |
| 2002-12-31 | $22.67 Million | -20.46% |
| 2001-12-31 | $28.50 Million | +4.52% |
| 2000-12-31 | $27.27 Million | +8.86% |
| 1999-12-31 | $25.05 Million | +13.52% |
| 1998-12-31 | $22.06 Million | -0.15% |
| 1997-12-31 | $22.10 Million | +2.93% |
| 1996-12-31 | $21.47 Million | -3.30% |
| 1995-12-31 | $22.20 Million | -21.55% |
| 1994-12-31 | $28.30 Million | -2.41% |
| 1993-12-31 | $29.00 Million | -7.94% |
| 1992-12-31 | $31.50 Million | +16.24% |
| 1991-12-31 | $27.10 Million | +141.96% |
| 1990-12-31 | $11.20 Million | +16.67% |
| 1989-12-31 | $9.60 Million | -- |